Where:
Online event
Admission:
$15
Categories:
Business, Classes, Innovation, Lectures & Conferences, Tech, Virtual & Streaming
Event website:
https://nevca.regfox.com/investor-ip-due-diligence-determining-in-house-vs-attorney-advised
New England Venture Capital Association (NEVCA) is hosting a Life Science VC Briefing this Wed. Feb 23 at 2 - 3 pm ET - open to the public!
"Investor Due Diligence - Reducing Legal Fees While Managing Risk: 'What can I do in-house and when do I need an attorney?'"
About the topic: Due diligence can be at once the most critical, the most complex, and the most costly element of the pre-investment process. Doing too much in-house can be risky, while attorney fees can skyrocket quickly. But there is a middle ground, and a roadmap to identifying it.
About the presenter: Dean Farmer has 20 years’ experience in IP strategy and portfolio development and IP litigation - preceded by a scientific career that includes a PhD in Organic Chemistry, an NIH Fellowship, and multiple publications - that he brings to the service of startups and emerging biotechs, as well as investors in the early stages of due diligence on these types of investment targets. In this program, Dean will use real life case studies to illustrate various issues - and break down the decision making process for due diligence resourcing.
Register: https://nevca.regfox.com/investor-ip-due-diligence-determining-in-house-vs-attorney-advised
Free for NEVCA Members, $15 for general public.